Hormone Replacement Therapy Market to Inspire a Growth up to US$ 16.62 Billion by 2026 – Coherent Market Insights
SEATTLE, April 12, 2021, (PHARMIWEB) — Hormone Replacement Therapy Market – Insights
Key players in the market are focused on adopting M&A strategies in order to enhance their market share, which is expected to boost growth of the market. For inatance, in 2014, Pfizer Inc., a U.S.-based pharmaceutical company, merged with OPKO Health Inc., a U.S.-based company, to develop a long acting growth hormone (hGH-CTP) and new therapies for growth hormone deficient patients. The hGH-CTP is easy to use and one injection can be administered in a week rather than daily doses. The U.S. Food and Drug Administration has designated hGH-CTP with orphan drug designation in the U.S. The growth hormone also received orphan drug designation in Europe for adults and children with growth hormone deficiency.
Increasing number of products in development phase is expected to boost growth of the hormone replacement therapy market. For instance, Somapacitan sponsored by Novo Nordisk A/S, a Denmark-based company, completed phase 3 clinical trials in 2017. This drug is used for the treatment of growth hormone deficiency in adults.
Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/2079
The global hormone replacement therapy market size was valued at US$ 10.58 billion in 2017 and is expected to witness a CAGR of 5.2% over the forecast period (2018 – 2026).
Global Hormone Replacement Therapy Market Share (%) Analysis, By Therapy Type 2017
Source: Coherent Market Insights Analysis (2018)
High incidence of chronic disorders is expected to propel demand for hormone replacement therapy
Increasing number of adult men suffering from hypogonadism is contributing to high demand for hormone replacement therapy. For instance, according to the European Association of Urology: 2016 report, in middle-aged men, the incidence of hypogonadism varies from 2.1% to 12.8%. The incidence of low testosterone and symptoms of hypogonadism in men aged 40-79 varies form 2.1% to 5.7%, in Europe.
Moreover, major governments worldwide are focused on supporting R&D in hormone replacement therapy, which is also expected to boost growth of the hormone replacement therapy market. For instance, NGOs such as the National Gaucher Society offer financial aid to patients requiring enzyme replacement therapy.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/hormone-replacement-therapy-market-to-surpass-us-1662-billion-by-2026-1099
Hormone Replacement Therapy Market Restraints
Major regulatory bodies worldwide have imposed stringent regulations for use of hormone replacement therapy and related products as these may make patient vulnerable to cardiovascular conditions. This scenario is expected to limit adoption of hormone replacement therapy, thereby hindering the market growth over the forecast period. For instance, in February 2018, the U.S. Food and Drug Administration updated its policies and stated that testosterone replacement product manufacturers need to change the labelling to inform the patients about possible increased risk of heart attack and stroke. Moreover, in January 2018, the agency proposed the regulation that required testosterone manufacturers to conduct a post-marketing randomized, double-blind, placebo-controlled trial, before marketing the product. Though this, manufacturers are required to assess if a particular treatment has adverse effects and if that may lead to cardiovascular diseases such as myocardial infarction and stroke.
Hormone Replacement Therapy Market – Regional Insights
The global hormone replacement therapy market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The market in North America is expected to account for the largest market share over the forecast period. Key players in the market are focused on approval and launch of new products and therapies in order to enhance their market share, which is expected to drive growth of the market over the forecast period.
The market is Europe is expected to follow North America in terms of market share. Key players in this market are focused on approval and launch of new therapies for the treatment of secondary hyperparathyroidism. Moreover, high prevalence of secondary hyperparathyroidism is also expected to contribute to growth of the market. For instance, in December 2016, Amgen received marketing approval from the European Commission for its drug etecalcetide (Parsabiv) for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney diseases.
High prevalence of chronic disorders, hypogonadism in men with type II diabetes mellitus, and diabetes is expected to increase demand for hormone replacement therapy in Asia Pacific. For instance, according to the International Diabetes Federation (IDF) Diabetes Atlas: 2017, number of people suffering from diabetes aged between 20 to 79 years in South East Asia and Western Pacific in 2017 was 82 million and 159 million, respectively.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2079
Global Hormone Replacement Therapy Market Value (US$ Mn) & Y-o-Y Growth (%)
Source: Coherent Market Insights Analysis (2018)
Hormone Replacement Therapy Market – Competitive Landscape
Key players in the market are focused on developing biologics of various drugs that can be used in management and treatment of hypothyroidism. For instance, in July 2017, Teva Pharmaceutical Industries Ltd. launched generic version of Vagifem (estradiol vaginal inserts), 10 mcg in the U.S. Estradiol vaginal inserts are estrogens indicated for the treatment of atrophic vaginitis due to menopause. Similarly, in December 2017, the U.S. FDA approved Abbreviated New Drug Application (ANDA) for Mylan N.V.’s Estradiol Vaginal Cream USP, 0.01%, following which the company launched this drug in the U.S. The product is the first generic version of Allergan’s Estrace Cream, indicated for the treatment of vulvar and vaginal atrophy. Mylan provides Estradiol in four delivery systems – cream, gel, transdermal patch, and tablet.
Key players operating in the global hormone replacement therapy market include, QuatRx Pharmaceuticals, Novartis AG, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S,Teva Pharmaceutical Industries Ltd., Amgen, Inc., Abbott Laboratories, Eli Lilly and Company, and Mylan N.V.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Therapy Type
- Market Snippet, By Route of Administration
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Pipeline Analysis
- Epidemiology
- Regulatory Scenario
- Reimbursement Scenario
- PORTER’S Five Forces
- PEST Analysis
- Market Dynamics
- Global Hormone Replacement Therapy Market, By Therapy Type, 2016 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Estrogen Replacement Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Human Growth Hormone (HGH) Replacement Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Thyroid Replacement Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Testosterone Replacement Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Hormone Replacement Therapy Market, By Route of Administration, 2016 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Hormone Replacement Therapy Market, By Application, 2016 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hypothyroidism
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Male Hypogonadism
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Growth Hormone Deficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Menopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Hormone Replacement Therapy Market, By Distribution Channel, 2016 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Hormone Replacement Therapy Market, By Region, 2016 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, By Region, 2016 – 2026
- Regional Trends
- North America
- Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- Northern Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
